[{"id":"dde197cc-e99a-4873-8dba-a63667fc0334","acronym":"","url":"https://clinicaltrials.gov/study/NCT06939283","created_at":"2025-06-28T16:10:57.563Z","updated_at":"2025-06-28T16:10:57.563Z","phase":"Phase 1/2","brief_title":"A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma","source_id_and_acronym":"NCT06939283","lead_sponsor":"Werewolf Therapeutics, Inc.","biomarkers":" PD-L1","pipe":"","alterations":" ","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e WTX-330"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 04/01/2025","start_date":" 04/01/2025","primary_txt":" Primary completion: 08/01/2028","primary_completion_date":" 08/01/2028","study_txt":" Completion: 08/01/2028","study_completion_date":" 08/01/2028","last_update_posted":"2025-04-22"}]